Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$10.96
-3.0%
$15.11
$6.39
$21.00
$499.16M1.19467,376 shs469,006 shs
Edap Tms S.A. stock logo
EDAP
Edap Tms
$1.78
+2.0%
$1.84
$1.26
$6.01
$66.37M0.1398,316 shs21,363 shs
FONAR Co. stock logo
FONR
FONAR
$14.35
+0.6%
$12.91
$12.00
$18.68
$89.01M117,130 shs83,537 shs
Zynex, Inc. stock logo
ZYXI
Zynex
$2.49
-3.9%
$2.26
$1.66
$10.62
$75.30M0.7161,531 shs126,923 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
-3.01%-3.86%-32.26%-43.59%+65.06%
Edap Tms S.A. stock logo
EDAP
Edap Tms
+1.98%+2.01%-18.58%-31.99%-69.50%
FONAR Co. stock logo
FONR
FONAR
+0.56%+4.74%+17.24%-2.71%-7.60%
Zynex, Inc. stock logo
ZYXI
Zynex
-3.86%+9.69%+11.16%-66.53%-75.37%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AxoGen, Inc. stock logo
AXGN
AxoGen
2.8842 of 5 stars
3.53.00.00.03.02.50.6
Edap Tms S.A. stock logo
EDAP
Edap Tms
2.8849 of 5 stars
3.25.00.00.02.81.70.6
FONAR Co. stock logo
FONR
FONAR
2.1839 of 5 stars
0.05.00.00.02.80.81.9
Zynex, Inc. stock logo
ZYXI
Zynex
2.9492 of 5 stars
3.20.00.00.02.22.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
3.00
Buy$22.20102.55% Upside
Edap Tms S.A. stock logo
EDAP
Edap Tms
2.33
Hold$8.50378.87% Upside
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
2.33
Hold$6.00140.96% Upside

Current Analyst Ratings Breakdown

Latest AXGN, EDAP, ZYXI, and FONR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Edap Tms S.A. stock logo
EDAP
Edap Tms
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral
5/13/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $24.00
4/30/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$5.00 ➝ $4.00
4/30/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $8.00
4/15/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform
4/4/2025
Edap Tms S.A. stock logo
EDAP
Edap Tms
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$8.00 ➝ $2.00
3/28/2025
Edap Tms S.A. stock logo
EDAP
Edap Tms
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$5.00 ➝ $4.50
3/28/2025
Edap Tms S.A. stock logo
EDAP
Edap Tms
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00 ➝ $19.00
3/17/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$11.00 ➝ $5.50
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$194.52M2.57N/AN/A$2.22 per share4.94
Edap Tms S.A. stock logo
EDAP
Edap Tms
$62.77M1.06N/AN/A$1.66 per share1.07
FONAR Co. stock logo
FONR
FONAR
$103.02M0.86$3.00 per share4.78$25.62 per share0.56
Zynex, Inc. stock logo
ZYXI
Zynex
$172.40M0.44$0.14 per share18.01$1.36 per share1.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$21.72M-$0.15N/AN/AN/A-7.91%-14.91%-7.49%8/14/2025 (Estimated)
Edap Tms S.A. stock logo
EDAP
Edap Tms
-$22.92M-$0.62N/AN/AN/A-34.92%-44.21%-25.88%N/A
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.2512.48N/A7.68%4.94%3.70%N/A
Zynex, Inc. stock logo
ZYXI
Zynex
$9.73M-$0.2416.605.30N/A2.49%13.05%3.78%7/23/2025 (Estimated)

Latest AXGN, EDAP, ZYXI, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Edap Tms S.A. stock logo
EDAP
Edap Tms
-$0.16-$0.20-$0.04-$0.20$16.56 million$16.37 million
5/15/2025Q3 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.37N/A$0.37N/AN/A
4/28/2025Q1 2025
Zynex, Inc. stock logo
ZYXI
Zynex
-$0.24-$0.33-$0.09-$0.33$30.83 million$26.58 million
3/27/2025Q4 2024
Edap Tms S.A. stock logo
EDAP
Edap Tms
-$0.11-$0.05+$0.06-$0.05$20.83 million$22.69 million
3/11/2025Q4 2024
Zynex, Inc. stock logo
ZYXI
Zynex
$0.09-$0.02-$0.11-$0.02$53.65 million$45.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Edap Tms S.A. stock logo
EDAP
Edap Tms
N/AN/AN/AN/AN/A
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.67
3.74
2.47
Edap Tms S.A. stock logo
EDAP
Edap Tms
0.08
2.18
1.46
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Zynex, Inc. stock logo
ZYXI
Zynex
1.66
3.94
3.15

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Edap Tms S.A. stock logo
EDAP
Edap Tms
62.74%
FONAR Co. stock logo
FONR
FONAR
50.64%
Zynex, Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
2.78%
Edap Tms S.A. stock logo
EDAP
Edap Tms
0.23%
FONAR Co. stock logo
FONR
FONAR
1.55%
Zynex, Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
45045.54 million40.93 millionOptionable
Edap Tms S.A. stock logo
EDAP
Edap Tms
23037.39 million37.02 millionOptionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Zynex, Inc. stock logo
ZYXI
Zynex
77030.24 million15.25 millionOptionable

Recent News About These Companies

Here’s Why Zynex (ZYXI) Fell in Q1

New MarketBeat Followers Over Time

Media Sentiment Over Time

AxoGen stock logo

AxoGen NASDAQ:AXGN

$10.96 -0.34 (-3.01%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$11.16 +0.19 (+1.78%)
As of 05/28/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Edap Tms stock logo

Edap Tms NASDAQ:EDAP

$1.77 +0.03 (+1.69%)
As of 05/28/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

FONAR stock logo

FONAR NASDAQ:FONR

$14.35 +0.08 (+0.56%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$14.36 +0.01 (+0.03%)
As of 05/28/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Zynex stock logo

Zynex NASDAQ:ZYXI

$2.49 -0.10 (-3.86%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$2.53 +0.04 (+1.65%)
As of 05/28/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.